Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients

Asberg, A., Humar, A., Rollag, H., Jardine, A. , Mouas, H., Pescovitz, M., Sgarabotto, D., Tuncer, M., Noronha, I. and Hartmann, A. (2007) Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. American Journal of Transplantation, 7, pp. 2106-2113. (doi: 10.1111/j.1600-6143.2007.01910.x)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Jardine, Professor Alan
Authors: Asberg, A., Humar, A., Rollag, H., Jardine, A., Mouas, H., Pescovitz, M., Sgarabotto, D., Tuncer, M., Noronha, I., and Hartmann, A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:American Journal of Transplantation
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:1600-6135

University Staff: Request a correction | Enlighten Editors: Update this record